Stay updated on BMS-986016 Safety Study with or without Nivolumab Clinical Trial
Sign up to get notified when there's something new on the BMS-986016 Safety Study with or without Nivolumab Clinical Trial page.

Latest updates to the BMS-986016 Safety Study with or without Nivolumab Clinical Trial page
- CheckyesterdayChange DetectedThe ClinicalTrials.gov page footer revision changed from v3.8.0 to v3.8.1.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe clinical trial record for BMS-986016, alone or with nivolumab, is displayed with study design, eligibility criteria, treatment arms, outcomes, and study dates. The previous page showed a 403 Forbidden error.SummaryDifference46%

- Check22 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.2 to v3.8.0; the page content remains a 403 Forbidden error.SummaryDifference0.2%

- Check29 days agoChange DetectedA banner announces NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference1%

- Check36 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check43 days agoChange DetectedThe site footer revision changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

Stay in the know with updates to BMS-986016 Safety Study with or without Nivolumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BMS-986016 Safety Study with or without Nivolumab Clinical Trial page.